Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia.
Niu X, Rothe K, Chen M, Grasedieck S, Li R, Nam SE, Zhang X, Novakovskiy GE, Ahn YH, Maksakova I, Lai S, Zhang H, Yan J, Liu H, Zhao Y, Wu D, Ge Y, Wasserman WW, Rouhi A, Kuchenbauer F, Yip CK, Zhang Z, Jiang X.
Niu X, et al. Among authors: ahn yh.
Blood. 2021 Jul 1;137(26):3641-3655. doi: 10.1182/blood.2020007651.
Blood. 2021.
PMID: 33786587
Free PMC article.